C Gazzaruso

Summary

Affiliation: Fondazione Salvatore Maugeri
Country: Italy

Publications

  1. ncbi Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
    C Gazzaruso
    IRCCS Maugeri Foundation Hospital, Section of Internal Medicine, Diabetes Centre, Pavia, Italy
    Diabet Med 18:589-94. 2001
  2. ncbi Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome
    Carmine Gazzaruso
    Internal Medicine Unit, Cardiovascular Prevention Clinic ASTRA, IRCCS Maugeri Foundation Hospital, Scientific Institute of Pavia, Italy
    J Hypertens 21:1377-82. 2003
  3. ncbi Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients
    Carmine Gazzaruso
    Diabetes Center, Internal Medicine Unit, Department of Internal Medicine and Medical Therapeutics, IRCCS Maugeri Foundation Hospital, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy
    J Diabetes Complications 17:135-40. 2003
  4. ncbi Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Via Ferrata 8, 27100 Pavia, Italy
    Obes Surg 12:841-5. 2002
  5. ncbi Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy
    Int J Cardiol 87:91-8. 2003
  6. ncbi Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism
    Carmine Gazzaruso
    Internal Medicine Unit, Diabetes Center, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
    Diabetes Care 25:1418-24. 2002
  7. ncbi Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease
    C Falcone
    Department of Cardiology, IRCCS San Matteo Hospital, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy
    Int J Cardiol 90:219-27. 2003
  8. ncbi Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients
    C Gazzaruso
    Interdepartmental Center for Research in Molecular Medicine CIRMC, University of Pavia and IRCCS Maugeri Foundation Hospital Pavia, Pavia, Italy
    Int J Impot Res 18:311-5. 2006
  9. ncbi Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Via Aselli 5, 27100 Pavia, Italy
    Expert Rev Cardiovasc Ther 4:173-80. 2006
  10. ncbi Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women
    Tiziana Montalcini
    Department of Medicina Sperimentale e Clinica G Salvatore, University of Catanzaro Magna Graecia, Viale Europa Germaneto, Catanzaro, Italy
    Diabetes Res Clin Pract 76:378-82. 2007

Collaborators

Detail Information

Publications22

  1. ncbi Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
    C Gazzaruso
    IRCCS Maugeri Foundation Hospital, Section of Internal Medicine, Diabetes Centre, Pavia, Italy
    Diabet Med 18:589-94. 2001
    ..We also examined whether there are differences in the distributions of Lp(a) levels and apo(a) phenotypes between CAD patients with and without diabetes...
  2. ncbi Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome
    Carmine Gazzaruso
    Internal Medicine Unit, Cardiovascular Prevention Clinic ASTRA, IRCCS Maugeri Foundation Hospital, Scientific Institute of Pavia, Italy
    J Hypertens 21:1377-82. 2003
    ....
  3. ncbi Lipoprotein(a), apolipoprotein(a) polymorphism and restenosis after intracoronary stent placement in Type 2 diabetic patients
    Carmine Gazzaruso
    Diabetes Center, Internal Medicine Unit, Department of Internal Medicine and Medical Therapeutics, IRCCS Maugeri Foundation Hospital, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy
    J Diabetes Complications 17:135-40. 2003
    ..On the contrary, Lp(a) and apo(a) polymorphisms do not appear to be reliable markers of restenosis in patients with Type 2 diabetes mellitus...
  4. ncbi Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Via Ferrata 8, 27100 Pavia, Italy
    Obes Surg 12:841-5. 2002
    ..The aim of the present longitudinal study was to evaluate the relationship between weight loss and changes in insulin-resistance and in the prevalence of the metabolic syndrome 1-year after SAGB implantation...
  5. ncbi Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role?
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy
    Int J Cardiol 87:91-8. 2003
    ..The aim of the present prospective study was to evaluate whether lipoprotein(a) levels and apolipoprotein(a) phenotypes are predictors of restenosis after elective stent implantation in patients with de novo lesions of coronary arteries...
  6. ncbi Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism
    Carmine Gazzaruso
    Internal Medicine Unit, Diabetes Center, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
    Diabetes Care 25:1418-24. 2002
    ..We investigated the association of Lp(a) and apo(a) polymorphism with angiographically documented asymptomatic CAD in type 2 diabetic patients without evident complications...
  7. ncbi Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease
    C Falcone
    Department of Cardiology, IRCCS San Matteo Hospital, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy
    Int J Cardiol 90:219-27. 2003
    ..The aim of the present study was to evaluate the prevalence of silent ischemia in diabetic and nondiabetic patients with assessed CAD...
  8. ncbi Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients
    C Gazzaruso
    Interdepartmental Center for Research in Molecular Medicine CIRMC, University of Pavia and IRCCS Maugeri Foundation Hospital Pavia, Pavia, Italy
    Int J Impot Res 18:311-5. 2006
    ..However, no correlation was found between the extent of angiographic CAD and the presence or the severity of ED...
  9. ncbi Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Via Aselli 5, 27100 Pavia, Italy
    Expert Rev Cardiovasc Ther 4:173-80. 2006
    ..Finally, recent guidelines on the treatment of erectile dysfunction with phosphodiesterase-5 inhibitors in diabetic patients with and without coronary artery disease have been reported and discussed...
  10. ncbi Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal women
    Tiziana Montalcini
    Department of Medicina Sperimentale e Clinica G Salvatore, University of Catanzaro Magna Graecia, Viale Europa Germaneto, Catanzaro, Italy
    Diabetes Res Clin Pract 76:378-82. 2007
    ..The purpose of this study was to investigate whether the subclinical carotid atherosclerosis prevalence is different in obese postmenopausal women with and without the metabolic syndrome...
  11. ncbi Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus
    Carmine Gazzaruso
    IRCCS Maugeri Foundation Hospital, Pavia, Italy
    Am J Cardiol 97:236-9. 2006
    ..Other studies are needed to establish whether metabolic syndrome and HOMA are reliable markers to identify diabetic patients for additional screening for silent CAD...
  12. ncbi Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease
    Piercarlo Minoretti
    Interdepartmental Center for Research in Molecular Medicine CIRMC, University of Pavia, Viale Taramelli 24, I 27100 Pavia, Italy
    Neurosci Lett 391:147-9. 2006
    ..37 (95% CI: 0.20-0.69, P=0.002). Our data further support a role for innate immunity in neurodegeneration and give the first evidence that the TLR4 Asp299Gly variant may be protective toward the development of LOAD...
  13. ncbi Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients
    Carmine Gazzaruso
    Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy
    Circulation 110:22-6. 2004
    ..In diabetic patients, CAD is often silent. Among diabetic patients with silent CAD, the prevalence of ED has never been evaluated. We investigated whether ED is associated with asymptomatic CAD in type 2 diabetic patients...
  14. ncbi High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk
    Raffaele Bruno
    J Acquir Immune Defic Syndr 31:363-5. 2002
  15. ncbi Prevalence of metabolic syndrome among HIV patients
    Carmine Gazzaruso
    Diabetes Care 25:1253-4. 2002
  16. ncbi [Current opinions on the relationships between atherosclerosis, type 2 diabetes mellitus and erectile dysfunction]
    Carmine Gazzaruso
    U O Medicina Interna, Presidio Ospedaliero di Sarnico, I R C C S Fondazione Salvatore Maugeri, Pavia
    Recenti Prog Med 96:155-8. 2005
    ..In particular, erectile dysfunction may be used as a predictor of silent or early athero-thrombotic diseases, especially in diabetic patients...
  17. ncbi Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus
    Sebastiano B Solerte
    Department of Internal Medicine, Geriatric Clinic, University of Pavia, Pavia, Italy
    Am J Cardiol 93:23A-29A. 2004
    ..We suggest that increased amino acid availability for skeletal muscle function and strength could ameliorate metabolic control and insulin sensitivity in elderly patients with poorly controlled type 2 diabetes...
  18. ncbi Endogenous testosterone and endothelial function in postmenopausal women
    Tiziana Montalcini
    Department of Medicina Sperimentale e Clinica G Salvatore, University of Catanzaro Magna Graecia, Catanzaro, Italy
    Coron Artery Dis 18:9-13. 2007
    ..The role of androgens is still controversial. The aim of the present study was to investigate the relationship between endogenous sex hormones and endothelial function, measuring the brachial artery flow-mediated dilation...
  19. doi Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors
    Carmine Gazzaruso
    Cardio Metabolic Unit and the Centre for Applied Clinical Research Ce R C A Clinical Institute Beato Matteo, Hospital Group San Donato, Vigevano, Italy
    J Am Coll Cardiol 51:2040-4. 2008
    ....
  20. doi Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia
    Sebastiano B Solerte
    Geriatric Clinic, Department of Internal Medicine, University of Pavia, Pavia, Italy
    Am J Cardiol 101:69E-77E. 2008
    ..The improvement in the amount of whole-body lean mass could be linked to increased insulin sensitivity and anabolic conditions related to IGF-1 availability...
  21. doi Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus
    Sebastiano B Solerte
    Geriatric Clinic, Department of Internal Medicine, University of Pavia, Pavia, Italy
    Am J Cardiol 101:82E-88E. 2008
    ..This effect was consistent during the long-term observation period of 60 weeks and was also present after the crossover from AAs to placebo...